A phase I dose-escalating and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer

Oncology
Jean Pierre DelordHenri Roche

Abstract

Docetaxel and vinorelbine are both active drugs as single agents in the treatment of metastatic breast cancer. We performed a phase I dose-escalating and pharmacokinetic study to assess the safety profile of a new combination regimen and the pharmacokinetic interaction of vinorelbine and docetaxel. Patients with metastatic breast cancer received first-line treatment with both drugs on days 1-5. Treatment was restarted on day 21 of each cycle. We had to stop the escalation at the first step of the study (vinorelbine 20 mg/m(2) followed by docetaxel 30 mg/m(2) on days 1 and 5) because of hematological toxicity. In 4 additional patients who received G-CSF supplementation, no major leukopenia occurred, suggesting that the toxicity profile of this combination is very homogenous and focused on neutrophils. We found no pharmacokinetic interaction between the two drugs. These results suggest that a pharmacodynamic interaction was the cause of the hematological toxicity and that sequential regimens should be preferably further explored.

References

Jan 1, 1989·American Journal of Industrial Medicine·D C MuirC D Bernholz
Feb 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A RomeroL Romero Acuña
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V A MillerM G Kris
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G V KornekW Scheithauer
Aug 28, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M CamponeN Azli
Mar 21, 2003·Cancer Chemotherapy and Pharmacology·M VassilomanolakisA P Efremidis

❮ Previous
Next ❯

Citations

Aug 7, 2008·Pharmacogenomics·Silvia FunkeJenny Chang-Claude
Aug 12, 2010·Thérapie·Pauline Gerritsen-van SchieveenUNKNOWN Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique
Sep 16, 2010·Fundamental & Clinical Pharmacology·Pauline Gerritsen-van SchieveenUNKNOWN Therapeutic drug monitoring group of the French Society of Pharmacology and Therapeutics

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.